- 31 October 2025
Respiratory adherence tool to enhance inhaled therapy and provides adherence and disease management
Keywords: Digital Health
Type
Digital solution and service (e.g. application/digital health portal/platform/AI based system/etc.)
we are developing and distributing AI based algorithms to coach daily inhalation. the algorithms run on any smartphone and are embedded in an App called Kata.
Short description
KATA® is the first AI-powered, FDA-cleared, CE-marked, medical device application that monitors and coaches correct inhaler use in real time, for any inhaler, on all smartphones, with no extra hardware.
It even works offline or without data plan, critical in underserved communities.
Kata is clinically proven – evaluated in 7 clinical trials and pilots, KATA reduced critical inhaler errors by 85-100%, outperforming most standard inhaler training and adherence programs.
Kata is well adopted by users, it is already in the hands of 2 500+ patients. VisionHealth has active Pharma and Medtech partnerships.
Evidence
Impact on health outcomes, Economic value to health and care systems, Contribution to citizen empowerment
Maturity
The practice/case/tool is “on the market” and integrated in routine use. There is proven market impact in terms of job creation/spin-off creation or other company growth
The application is availiable in Europe, and distributed in Germany and USA via partners.
Countries
Germany
Other (please specify in free text box below)
Other (please specify in free text box below)
USA
Geographical scope
European
In Europe, we started in Germany, but would like to roll out to other countries, resources permitting.
Language(s)
German, English, Spanish
Comment
Kata is used by more than 2500 patients. Additionally to our Medtech partnership in the US, we will be starting pilots at Columbia University and University of MIchigan serving Medicaid patients.
Submitted in other database or repository of digital health resources that is publicly available
no
Additional information
Relations
to clinicians / care practitioners
Health data analytics (Artificial Intelligence/algorithm development and calibration/machine learning/risk stratification tools/etc.)
Care pathway tracking and adherence
Care pathway tracking and adherence
to patients / citizens
Remote monitoring apps/health outcomes tracking
Primary target patient group (age)
Youth and young adults (15-24), Adults (25-64), Older adults (65+)
Addressed prevention area(s)
Education
educating on effective use of inhaler technique
Use case and care pathway positioning
Treatment, Disease monitoring, treatment compliance, self-management
Ready to be transferred to
The practice has been transferred in other locations, regions or national scale in the same country.
Plans for cross-border implementation
Are considered and will be developed in the near future